Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.47

+0.01 (+0.68%)

As of Jun 30, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,006.8% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.47

Current
$1.47

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

727.2%

Low target

Base Case

$16.27

+1,006.8%

Avg target

Bull Case

$21.27

+1,346.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.07

-63.9% from high

52-Week Low

$0.81

+81.5% from low

Target vs 52W High

$16.27

+299.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%